Butalbital
As of the edition of 20 October 2026, Butalbital is a small molecule: marketed, first approved in 1970 (CA); acts on GABRB1, GABRB2 and GABRB3.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1986
- Kind
- Small molecule
- Brand name
- Fiorinal
- First approved
- 31 December 1970 (CA)
- Approvals on record
- 6 in 2 regions
- Holder of the most recent approval
- Actavis Laboratories Ut; 3 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Aralez Pharmaceuticals | Applicant | 1970 to now |